hyaluronoglucosaminidase has been researched along with Glycogen Storage Disease Type II in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campbell, GA; Cheng, S; Grady, J; Kaye, E; Matalon, R; Michals-Matalon, K; Surendran, S; Tyring, SK | 1 |
| Kunze, K; Lange, RH; Lück, R; Platt, D | 1 |
2 other study(ies) available for hyaluronoglucosaminidase and Glycogen Storage Disease Type II
| Article | Year |
|---|---|
Hyaluronidase increases the biodistribution of acid alpha-1,4 glucosidase in the muscle of Pompe disease mice: an approach to enhance the efficacy of enzyme replacement therapy.
Topics: alpha-Glucosidases; Animals; Glycogen Storage Disease Type II; Hyaluronoglucosaminidase; Injections, Intraperitoneal; Injections, Intravenous; Mice; Muscle, Skeletal; Organ Specificity; Tissue Distribution; Treatment Outcome | 2006 |
[Clinical, biochemical, morphological and electrophysiological studies of glycogenosis Type II in childhood with double deficiency of enzymes (author's transl)].
Topics: Glucosidases; Glucuronidase; Glycogen; Glycogen Storage Disease; Glycogen Storage Disease Type II; Glycosaminoglycans; Hexosaminidases; Humans; Hyaluronoglucosaminidase; Infant; Kidney; Liver; Muscles; Myofibrils; Spleen; Vacuoles | 1975 |